Vernal is excited to announce its new partnership with REPROCELL, furthering our mission to democratize access to mRNA, a life-changing technology, around the world. REPROCELL is a trusted leader in iPSC reprograming technologies and GMP iPSC manufacturing based in Japan. Together with REPROCELL, we are pleased to extend access to our clients in Japan for mRNA therapeutic modalities. Check out the News-Medical or UK Healthcare announcement and then contact us at [email protected] to learn more about how we can partner with you too!
